SRGN expression is transcriptionally upregulated by NRF2 activation and epigenetically induced through nicotinamide N-methyltransferase-induced perturbation of methionine metabolism in TTF-1–negative lung adenocarcinoma [70]. The gene discussed is TTF1; the disease is lung adenocarcinoma.